cancer
-
NuclearSHINE Raises $240 Million in Funding to Advance Commercial Fusion Technology
Nuclear fusion group SHINE Technologies said it has raised $240 million in equity funding to advance the company’s commercial fusion technology.
-
NuclearNRC Scraps Study to Determine Cancer Risks in Populations Living Near Nuclear Plants
The Nuclear Regulatory Commission (NRC) has dropped a study begun in 2010 to determine cancer risks in populations near U.S. nuclear power facilities. Continuing the work was “impractical, given the significant amount of time and resources needed and the agency’s current budget constraints,” the regulatory body said. The study that was being conducted by the […]